Vozmozhnosti kupirovaniya boli pri sindrome razdrazhennogo kishechnika


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The article reflects the current views on the issues of the pathophysiology, clinical manifestation and treatment of irritable bowel syndrome (IBS). Particular attention is paid to problems of low knowledge of physicians of backbone of IBS and approaches to its treatment. The evidence base on the use of myotropic antispasmodics in the treatment of IBS are analyzed in detail. The evidence of efficacy and safety of hyoscine butylbromide in this pathology are presented.

Full Text

Restricted Access

References

  1. Маев И.В., Кучерявый Ю.А, Черемушкин С.В. Эволюция представлений о синдроме раздраженного кишечника. Методическое пособие для врачей. Москва, 2013. 80 c.
  2. Черемушкин С.В., Маев И.В., Кучерявый Ю.А., Черемушкина Н.В. Спазмолитики при синдроме раздраженного кишечника с позиций доказательной медицины // Врач 2012. № 1. С. 45-52.
  3. Alvarez WC. The motor functions of the intestine from a new point of view. JAMA 1915; 65:388-94.
  4. Andrews EB, Eaton SC, Hollis KA, et al. Prevalence and demographics of irritable bowel syndrome: results from a large Web-based survey. Aliment Pharmacol Ther 2005;22:935-42.
  5. Brandt L, Chey W, Foxx-Orenstein A, et al. An evidence-based position statement on the management of irritable bowel syndrome. Am J Gastroenterol 2009;104(1):1-35.
  6. Camilleri M. Do the symptom-based, Rome criteria of irritable bowel syndrome lead to better diagnosis and treatment outcomes? The con argument. Clin Gastroenterol Hepatol 2009;8:129.
  7. Camilleri M, McKinzie S, Busciglio I, et al. Prospective study of motor, sensory, psychologic, and autonomic functions in patients with irritable bowel syndrome. Clin Gastroenterol Hepatol 2008(6):772-81.
  8. Chaudhary NA, Truelove SC. The irritable colon syndrome: a study of the clinical features, predisposing causes, and prognosis in 130 cases. Q J Med 1962;31:307-23.
  9. Darvish-Damavandi M, Nikfar S, Abdollahi M. A systematic review of efficacy and tolerability of mebeverin in irritable bowel syndrome. World J Gastroenterol 2010;16(5):547-53.
  10. Drossman DA. The Functional Gastrointestinal Disorders and the Rome III Process. Gastroenterology 2006;130(5):1377-90.
  11. Ford AC, Talley NJ, Spiegel BM. et al. Effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: systematic review and meta-analysis. BMJ (Clinical research ed.) 2008;337:a2313.
  12. Ge Z, Yuan Y, Zhang S, et al. Efficacy and tolerability of two oral hyoscine butylbromide formulations in Chinese patients with recurrent episodes of self-reported gastric or intestinal spasm-like pain. Int J Clin Pharmacol Ther 2011;49(3):198-205.
  13. Glasgow R, Mulvihil S. Abdominal pain, including the acute abdomen. Sleisenger & Fordtrans's Gastroentestinal and Liver Disease. Philadelphia; London; Toronto; Monreal; Sydney; Tokyo 2003;1:80-90.
  14. Hahn BA, Yan S, Strassels S. Impact of irritable bowel syndrome on quality of life and resource use in the United States and United Kingdom. Digestion 1999;60:77-81.
  15. International Foundation for Functional Gastrointestinal Disorders. IBS in the Real World Survey. Summary findings. Website. 2007.
  16. Levy RL, Jones KR, Whitehead WE, et al. Irritable bowel syndrome in twins: heredity and social learning both contribute to etiology. Gastroenterology 2001;121:799-804.
  17. Manning AP, Thompson WG, Heaton KW, Morris AF. Towards positive diagnosis of the irritable bowel. BMJ 1978;2:653-54.
  18. Mayer EM, Hays RD, Kilbourne A, et al. Impact of irritable bowel syndrome on health-related quality of life. Gastroenterology 1999;116:A1038.
  19. McKee DP, Quigley EM. Intestinal motility in irritable bowel syndrome: Is IBS a motility disorder? Part 1. Definition of IBS and colonic motility. Dig Dis Sci 1993;38:1761-62.
  20. Mertz H, Naliboff B, Munakata J, Niazi N, Mayer EA. Altered rectal perception is a biological marker of patients with irritable bowel syndrome. Gastroenterology 1995 109:40-52.
  21. Naliboff BD, Derbyshire S.W, Munakata J, et al. Cerebral activation in patients with irritable bowel syndrome and control subjects during rectosigmoid stimulation. Psychosom Med 2001;63(3):365-75.
  22. Nigam P. Different therapeutic regimens in irritable bowel syndrome J Assoc Physicians1984;32(12):1041-44.
  23. Owens DM, Nelson DK, Talley NJ. The irritable bowel syndrome: long-term prognosis and the physician-patient interaction. Ann Intern Med 1995;122:107-12.
  24. Poynard T, Regimbeau C, Benhamou Y. Metaanalysis of smooth muscle relaxants in the treatment of irritable bowel syndrome. Aliment Pharmacol Ther 2001;15(3):355-61.
  25. Ruepert L, Quartero AO, de Wit NJ, et al. Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome. Cochrane Database of Systematic Reviews 2011, Issue 8.
  26. Schafer E, Ewe K. Efficacy and tolerability of Buscopan Plus, Buscopan, paracetamol and placebo in outpatients with IBS. Fortschr Med 1990;108(25):488-92.
  27. Spiller RC, Jenkins D, Thornley JP, et al. Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut 2000;47(6):804-11.
  28. Spiller RC, Lam C. An Update on post-infectious irritable bowel syndrome: Role of genetics, immune activation, serotonin and altered microbiome. J Neurogastroenterol Motil 2012;18(3):258-68.
  29. Tytgat GN. Hyoscine butylbromide: a review of its use in the treatment of abdominal cramping and pain. Drugs 2007;67(9):1343-57.
  30. van der Veek PP, van den Berg M, de Kroon YE, et al. Role of tumor necrosis factor-alpha and interleukin-10 gene polymorphisms in irritable bowel syndrome. Am J Gastroenterol 2005;100:2510-16.
  31. World Gastroenterology Organization. Global Guideline. Irritable bowel syndrome: a global perspective. 2009.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2013 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies